A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVI
Conditions
Interventions
- DRUG: Ticagrelor plus ASA
- DRUG: Clopidogrel plus ASA
Sponsor
University of Athens